Dayanan, Baby Jane .
HRN: 23-44-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2023
CEFUROXIME 750MG (VIAL)
07/28/2023
08/03/2023
IVT
750mg
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes